ISRO and DBT inked a Mou to conduct biotechnology experiments in the space station

Current Context: On October 25, 2024, the Indian Space Research Organisation (ISRO) and the Department of Biotechnology (DBT) signed a memorandum of understanding in New Delhi.

• The agreement aims to conduct biotechnology experiments aboard India's proposed space station, the Bharatiya Antariksh Station (BAS), expected to be operational between 2028 and 2035.
• Key Highlights:
• Objective: To leverage space conditions for groundbreaking research in biotechnology, focusing on areas such as microgravity effects on muscle loss, algae as a sustainable food source, and biofuel production.
• Benefits: These experiments will enhance understanding of biological processes in space, improve human health research, and contribute to the development of sustainable bio-based technologies.
• Implementation: The experiments will be conducted in the BAS, India's indigenous space station, positioning the country as a leader in human spaceflight and long-duration missions.

Question:

1 What is the objective of the Mou between the Indian Space Research Organisation (ISRO) and the Department of Biotechnology (DBT)?

• A) To enhance space tourism
• B) To conduct biotechnology experiments in space
• C) To develop new satellite technology
• D) To explore outer planets

Answer: B) The agreement aims to conduct biotechnology experiments aboard India's proposed space station, the Bharatiya Antariksh Station (BAS), expected to be operational between 2028 and 2035.